This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Ethicon, Gmbh, Mcneil-Ppc, Inc.. Active years: 1993-2007.
Company Filing History:
Years Active: 1993-2007
Title: The Innovative Work of Inventor Ram L Kataria
Introduction:
Ram L Kataria, a talented inventor based in Hamilton Square, NJ, has made significant contributions to the field of sustained-release drug delivery systems. With a total of 6 patents under his name, Kataria's work has revolutionized the way therapeutic agents are administered in the body.
Latest Patents:
1. Compositions for parenteral administration and sustained-release of therapeutic agents: This patent focuses on parenterally-administrable microparticles designed to deliver therapeutic agents in a sustained-release manner. The innovative microparticles consist of a polymeric core containing the therapeutic agent, encapsulated by biodegradable polymers for controlled release.
2. Polymer coated microparticles for sustained release: Kataria's invention involves a sustained-release microparticle formulation for the parenteral administration of biologically active substances. The coated microparticles utilize a synthetic, bioabsorbable polymeric wax coating, offering controlled release properties for effective drug delivery.
Career Highlights:
Kataria has showcased his expertise while working at renowned companies such as Ethicon and McNeil-PPC. His groundbreaking inventions have paved the way for advanced drug delivery systems, earning him recognition in the pharmaceutical industry.
Collaborations:
Throughout his career, Kataria has collaborated with esteemed professionals in the field, including Joel S Rosenblatt and Shmuel Dabi. These collaborations have enriched his work and led to the development of innovative solutions in drug delivery technology.
Conclusion:
Inventor Ram L Kataria's relentless dedication to enhancing drug delivery systems through sustained-release technologies has left a lasting impact on the healthcare industry. His patents and collaborations stand as a testament to his commitment to advancing medical innovations for the benefit of patients worldwide.